Click here to get full coverage on Is Soleno Therapeutics (NASDAQ:SLNO) Using Debt Sensibly? - 富途牛牛

Is Soleno Therapeutics (NASDAQ:SLNO) Using Debt Sensibly?  富途牛牛

Is Soleno Therapeutics (NASDAQ:SLNO) Using Debt Sensibly? - 富途牛牛

Click here to get full coverage on Soleno Therapeutics (SLNO) Valuation Check After Wolfe Research’s Optimistic New Coverage and Stock Pop - Yahoo Finance

Soleno Therapeutics (SLNO) Valuation Check After Wolfe Research’s Optimistic New Coverage and Stock Pop  Yahoo Finance

Soleno Therapeutics (SLNO) Valuation Check After Wolfe Research’s Optimistic New Coverage and Stock Pop - Yahoo Finance

Click here to get full coverage on Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses - PR Newswire

Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses  PR Newswire

Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses - PR Newswire

Click here to get full coverage on Soleno Therapeutics (SLNO) Reports Strong Q3 Earnings Despite VYKAT XR Safety Concerns - MSN

Soleno Therapeutics (SLNO) Reports Strong Q3 Earnings Despite VYKAT XR Safety Concerns  MSN

Soleno Therapeutics (SLNO) Reports Strong Q3 Earnings Despite VYKAT XR Safety Concerns - MSN

Click here to get full coverage on Reassessing Soleno Therapeutics (SLNO) Valuation After Wolfe Research’s Confidence Boost and Improving Fundamentals - Sahm

Reassessing Soleno Therapeutics (SLNO) Valuation After Wolfe Research’s Confidence Boost and Improving Fundamentals  Sahm

Reassessing Soleno Therapeutics (SLNO) Valuation After Wolfe Research’s Confidence Boost and Improving Fundamentals - Sahm

Click here to get full coverage on 34,840 Shares in Soleno Therapeutics, Inc. $SLNO Purchased by Castleark Management LLC - MarketBeat

34,840 Shares in Soleno Therapeutics, Inc. $SLNO Purchased by Castleark Management LLC  MarketBeat

34,840 Shares in Soleno Therapeutics, Inc. $SLNO Purchased by Castleark Management LLC - MarketBeat

Click here to get full coverage on How Soleno Therapeutics' Audit Committee Leadership Transition At Soleno Therapeutics (SLNO) Has Changed Its Investment Story - Yahoo Finance

How Soleno Therapeutics' Audit Committee Leadership Transition At Soleno Therapeutics (SLNO) Has Changed Its Investment Story  Yahoo Finance

How Soleno Therapeutics' Audit Committee Leadership Transition At Soleno Therapeutics (SLNO) Has Changed Its Investment Story - Yahoo Finance

Click here to get full coverage on Soleno Therapeutics (SLNO) Faces Investor Scrutiny Amid Disappointing VYKATÔ XR Starts, Discontinuations; Shares Down 26% -- Hagens Berman - PR Newswire

Soleno Therapeutics (SLNO) Faces Investor Scrutiny Amid Disappointing VYKATÔ XR Starts, Discontinuations; Shares Down 26% -- Hagens Berman  PR Newswire

Soleno Therapeutics (SLNO) Faces Investor Scrutiny Amid Disappointing VYKATÔ XR Starts, Discontinuations; Shares Down 26% -- Hagens Berman - PR Newswire

Click here to get full coverage on Is Soleno Therapeutics, Inc. (SLNO) The Cheap Healthcare Stock To Buy Heading Into 2026? - Yahoo Finance

Is Soleno Therapeutics, Inc. (SLNO) The Cheap Healthcare Stock To Buy Heading Into 2026?  Yahoo Finance

Is Soleno Therapeutics, Inc. (SLNO) The Cheap Healthcare Stock To Buy Heading Into 2026? - Yahoo Finance

Click here to get full coverage on Soleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report -- Hagens Berman - PR Newswire

Soleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report -- Hagens Berman  PR Newswire

Soleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report -- Hagens Berman - PR Newswire

Click here to get full coverage on Soleno Therapeutics (SLNO): Losses Accelerate 43.6% Annually, Challenging Bullish Profitability Narrative - Yahoo Finance

Soleno Therapeutics (SLNO): Losses Accelerate 43.6% Annually, Challenging Bullish Profitability Narrative  Yahoo Finance

Soleno Therapeutics (SLNO): Losses Accelerate 43.6% Annually, Challenging Bullish Profitability Narrative - Yahoo Finance

Click here to get full coverage on Soleno Therapeutics (SLNO) Jumps 13.46% as Competitor Fails Prader-Willi Treatment Trial - Yahoo Finance

Soleno Therapeutics (SLNO) Jumps 13.46% as Competitor Fails Prader-Willi Treatment Trial  Yahoo Finance

Soleno Therapeutics (SLNO) Jumps 13.46% as Competitor Fails Prader-Willi Treatment Trial - Yahoo Finance

Click here to get full coverage on Soleno Therapeutics Inc (SLNO) Q3 2025 Earnings Report Preview: What To Look For - Yahoo Finance

Soleno Therapeutics Inc (SLNO) Q3 2025 Earnings Report Preview: What To Look For  Yahoo Finance

Soleno Therapeutics Inc (SLNO) Q3 2025 Earnings Report Preview: What To Look For - Yahoo Finance

Click here to get full coverage on Soleno Therapeutics (SLNO): Reassessing Valuation After VYKAT XR Safety Debate and Analyst Support - Yahoo Finance

Soleno Therapeutics (SLNO): Reassessing Valuation After VYKAT XR Safety Debate and Analyst Support  Yahoo Finance

Soleno Therapeutics (SLNO): Reassessing Valuation After VYKAT XR Safety Debate and Analyst Support - Yahoo Finance

Click here to get full coverage on Soleno Therapeutics (SLNO) Falls Hard on Patient Death - Yahoo Finance

Soleno Therapeutics (SLNO) Falls Hard on Patient Death  Yahoo Finance

Soleno Therapeutics (SLNO) Falls Hard on Patient Death - Yahoo Finance

Click here to get full coverage on Wells Fargo Reiterates a Buy Rating on Soleno Therapeutics (SLNO), Sets a PT of $123 - Yahoo Finance

Wells Fargo Reiterates a Buy Rating on Soleno Therapeutics (SLNO), Sets a PT of $123  Yahoo Finance

Wells Fargo Reiterates a Buy Rating on Soleno Therapeutics (SLNO), Sets a PT of $123 - Yahoo Finance

Click here to get full coverage on Soleno Therapeutics, Inc. (SLNO) Targets EMA Approval as U.S. Launch of VYKAT XR Expands - Yahoo Finance

Soleno Therapeutics, Inc. (SLNO) Targets EMA Approval as U.S. Launch of VYKAT XR Expands  Yahoo Finance

Soleno Therapeutics, Inc. (SLNO) Targets EMA Approval as U.S. Launch of VYKAT XR Expands - Yahoo Finance

Click here to get full coverage on Here's Why Momentum in Soleno Therapeutics (SLNO) Should Keep going - Yahoo Finance

Here's Why Momentum in Soleno Therapeutics (SLNO) Should Keep going  Yahoo Finance

Here's Why Momentum in Soleno Therapeutics (SLNO) Should Keep going - Yahoo Finance

Click here to get full coverage on Piper Sandler Maintains a Buy Rating on Soleno Therapeutics (SLNO), Sets a $145 PT - Yahoo Finance

Piper Sandler Maintains a Buy Rating on Soleno Therapeutics (SLNO), Sets a $145 PT  Yahoo Finance

Piper Sandler Maintains a Buy Rating on Soleno Therapeutics (SLNO), Sets a $145 PT - Yahoo Finance

Click here to get full coverage on Here’s Why Analysts are Bullish on Soleno Therapeutics (SLNO) - Yahoo Finance

Here’s Why Analysts are Bullish on Soleno Therapeutics (SLNO)  Yahoo Finance

Here’s Why Analysts are Bullish on Soleno Therapeutics (SLNO) - Yahoo Finance

Click here to get full coverage on Will Vykat XR Approval and Board Shift Reshape Soleno Therapeutics' (SLNO) Investment Narrative? - Sahm

Will Vykat XR Approval and Board Shift Reshape Soleno Therapeutics' (SLNO) Investment Narrative?  Sahm

Will Vykat XR Approval and Board Shift Reshape Soleno Therapeutics' (SLNO) Investment Narrative? - Sahm

Click here to get full coverage on Soleno Therapeutics, Inc. $SLNO Shares Sold by Holocene Advisors LP - MarketBeat

Soleno Therapeutics, Inc. $SLNO Shares Sold by Holocene Advisors LP  MarketBeat

Soleno Therapeutics, Inc. $SLNO Shares Sold by Holocene Advisors LP - MarketBeat

Click here to get full coverage on Adage Capital Partners GP L.L.C. Decreases Position in Soleno Therapeutics, Inc. $SLNO - MarketBeat

Adage Capital Partners GP L.L.C. Decreases Position in Soleno Therapeutics, Inc. $SLNO  MarketBeat

Adage Capital Partners GP L.L.C. Decreases Position in Soleno Therapeutics, Inc. $SLNO - MarketBeat

Click here to get full coverage on Soleno Therapeutics (SLNO): Does Current Valuation Signal Opportunity or Caution for Investors? - Yahoo Finance

Soleno Therapeutics (SLNO): Does Current Valuation Signal Opportunity or Caution for Investors?  Yahoo Finance

Soleno Therapeutics (SLNO): Does Current Valuation Signal Opportunity or Caution for Investors? - Yahoo Finance

Click here to get full coverage on How Much Upside is Left in Soleno Therapeutics (SLNO)? Wall Street Analysts Think 43.15% - Yahoo Finance

How Much Upside is Left in Soleno Therapeutics (SLNO)? Wall Street Analysts Think 43.15%  Yahoo Finance

How Much Upside is Left in Soleno Therapeutics (SLNO)? Wall Street Analysts Think 43.15% - Yahoo Finance

Click here to get full coverage on Down 21.7% in 4 Weeks, Here's Why Soleno Therapeutics (SLNO) Looks Ripe for a Turnaround - Yahoo Finance

Down 21.7% in 4 Weeks, Here's Why Soleno Therapeutics (SLNO) Looks Ripe for a Turnaround  Yahoo Finance

Down 21.7% in 4 Weeks, Here's Why Soleno Therapeutics (SLNO) Looks Ripe for a Turnaround - Yahoo Finance

Click here to get full coverage on SLNO INVESTIGATION ALERT: Investigation Launched into - GlobeNewswire

SLNO INVESTIGATION ALERT: Investigation Launched into  GlobeNewswire

SLNO INVESTIGATION ALERT: Investigation Launched into - GlobeNewswire

Click here to get full coverage on Wolfe Research Initiates Soleno Therapeutics (SLNO) Coverage with Outperform Rating, $75 PT, Dismisses Patient Slowdown Concerns - Yahoo Finance

Wolfe Research Initiates Soleno Therapeutics (SLNO) Coverage with Outperform Rating, $75 PT, Dismisses Patient Slowdown Concerns  Yahoo Finance

Wolfe Research Initiates Soleno Therapeutics (SLNO) Coverage with Outperform Rating, $75 PT, Dismisses Patient Slowdown Concerns - Yahoo Finance

Click here to get full coverage on Goldman Sachs Initiates Coverage of Soleno Therapeutics (SLNO) With a Buy Rating - Yahoo Finance

Goldman Sachs Initiates Coverage of Soleno Therapeutics (SLNO) With a Buy Rating  Yahoo Finance

Goldman Sachs Initiates Coverage of Soleno Therapeutics (SLNO) With a Buy Rating - Yahoo Finance

Click here to get full coverage on Soleno Therapeutics (NASDAQ: SLNO) sets November talks at Guggenheim and Jefferies - Stock Titan

Soleno Therapeutics (NASDAQ: SLNO) sets November talks at Guggenheim and Jefferies  Stock Titan

Soleno Therapeutics (NASDAQ: SLNO) sets November talks at Guggenheim and Jefferies - Stock Titan

Click here to get full coverage on Soleno stock plunges despite Q3 beat (SLNO:NASDAQ) - Seeking Alpha

Soleno stock plunges despite Q3 beat (SLNO:NASDAQ)  Seeking Alpha

Soleno stock plunges despite Q3 beat (SLNO:NASDAQ) - Seeking Alpha

Click here to get full coverage on How Does Wolfe Research’s Support Shape Soleno Therapeutics’ (SLNO) Credibility Amid Heightened Scrutiny? - Sahm

How Does Wolfe Research’s Support Shape Soleno Therapeutics’ (SLNO) Credibility Amid Heightened Scrutiny?  Sahm

How Does Wolfe Research’s Support Shape Soleno Therapeutics’ (SLNO) Credibility Amid Heightened Scrutiny? - Sahm

Click here to get full coverage on Marshall Wace LLP Purchases 164,580 Shares of Soleno Therapeutics, Inc. $SLNO - MarketBeat

Marshall Wace LLP Purchases 164,580 Shares of Soleno Therapeutics, Inc. $SLNO  MarketBeat

Marshall Wace LLP Purchases 164,580 Shares of Soleno Therapeutics, Inc. $SLNO - MarketBeat

Click here to get full coverage on $SLNO stock is down 13% today. Here's what we see in our data. - Quiver Quantitative

$SLNO stock is down 13% today. Here's what we see in our data.  Quiver Quantitative

$SLNO stock is down 13% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Are Legal Probes Shaping Trust in Soleno Therapeutics’ (SLNO) Drug Pipeline and Investor Relations? - Yahoo Finance

Are Legal Probes Shaping Trust in Soleno Therapeutics’ (SLNO) Drug Pipeline and Investor Relations?  Yahoo Finance

Are Legal Probes Shaping Trust in Soleno Therapeutics’ (SLNO) Drug Pipeline and Investor Relations? - Yahoo Finance

Click here to get full coverage on TD Cowen Starts Coverage Soleno Therapeutics (SLNO) Stock, Gives Buy - Yahoo Finance

TD Cowen Starts Coverage Soleno Therapeutics (SLNO) Stock, Gives Buy  Yahoo Finance

TD Cowen Starts Coverage Soleno Therapeutics (SLNO) Stock, Gives Buy - Yahoo Finance

Click here to get full coverage on Soleno Therapeutics (NASDAQ:SLNO) Shares Gap Up - What's Next? - MarketBeat

Soleno Therapeutics (NASDAQ:SLNO) Shares Gap Up - What's Next?  MarketBeat

Soleno Therapeutics (NASDAQ:SLNO) Shares Gap Up - What's Next? - MarketBeat

Click here to get full coverage on Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat

Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives Consensus Recommendation of "Buy" from Analysts  MarketBeat

Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat

Click here to get full coverage on Soleno Therapeutics (NASDAQ:SLNO) Nasdaq Index Clinical Pipeline Growth - Kalkine Media

Soleno Therapeutics (NASDAQ:SLNO) Nasdaq Index Clinical Pipeline Growth  Kalkine Media

Soleno Therapeutics (NASDAQ:SLNO) Nasdaq Index Clinical Pipeline Growth - Kalkine Media

Click here to get full coverage on Soleno Therapeutics, Inc. (SLNO): A Bull Case Theory - Yahoo Finance

Soleno Therapeutics, Inc. (SLNO): A Bull Case Theory  Yahoo Finance

Soleno Therapeutics, Inc. (SLNO): A Bull Case Theory - Yahoo Finance

Click here to get full coverage on Rhumbline Advisers Acquires 22,607 Shares of Soleno Therapeutics, Inc. $SLNO - MarketBeat

Rhumbline Advisers Acquires 22,607 Shares of Soleno Therapeutics, Inc. $SLNO  MarketBeat

Rhumbline Advisers Acquires 22,607 Shares of Soleno Therapeutics, Inc. $SLNO - MarketBeat

Click here to get full coverage on INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO - PR Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO  PR Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO - PR Newswire

Click here to get full coverage on Soleno Therapeutics gains amind renewed takeover speculation (SLNO:NASDAQ) - Seeking Alpha

Soleno Therapeutics gains amind renewed takeover speculation (SLNO:NASDAQ)  Seeking Alpha

Soleno Therapeutics gains amind renewed takeover speculation (SLNO:NASDAQ) - Seeking Alpha

Click here to get full coverage on Soleno Therapeutics (SLNO) Ends 26% Lower After Q3 Earnings - Yahoo Finance

Soleno Therapeutics (SLNO) Ends 26% Lower After Q3 Earnings  Yahoo Finance

Soleno Therapeutics (SLNO) Ends 26% Lower After Q3 Earnings - Yahoo Finance

Click here to get full coverage on Soleno Therapeutics (NASDAQ: SLNO) enters $100M ASR; 1,511,553 shares initially - Stock Titan

Soleno Therapeutics (NASDAQ: SLNO) enters $100M ASR; 1,511,553 shares initially  Stock Titan

Soleno Therapeutics (NASDAQ: SLNO) enters $100M ASR; 1,511,553 shares initially - Stock Titan

Click here to get full coverage on Soleno Therapeutics (SLNO) Loses 26% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance

Soleno Therapeutics (SLNO) Loses 26% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner  Yahoo Finance

Soleno Therapeutics (SLNO) Loses 26% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance

Click here to get full coverage on INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Soleno Therapeutics, Inc. (NASDAQ: SLNO) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm - PR Newswire

INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Soleno Therapeutics, Inc. (NASDAQ: SLNO) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm  PR Newswire

INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Soleno Therapeutics, Inc. (NASDAQ: SLNO) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm - PR Newswire

Click here to get full coverage on Here's Why Momentum in Soleno Therapeutics (SLNO) Should Keep going - Nasdaq

Here's Why Momentum in Soleno Therapeutics (SLNO) Should Keep going  Nasdaq

Here's Why Momentum in Soleno Therapeutics (SLNO) Should Keep going - Nasdaq

Click here to get full coverage on Soleno Therapeutics, Inc. (SLNO) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance

Soleno Therapeutics, Inc. (SLNO) Reports Q2 Loss, Tops Revenue Estimates  Yahoo Finance

Soleno Therapeutics, Inc. (SLNO) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance

Click here to get full coverage on Franklin Resources Inc. Buys New Shares in Soleno Therapeutics, Inc. $SLNO - MarketBeat

Franklin Resources Inc. Buys New Shares in Soleno Therapeutics, Inc. $SLNO  MarketBeat

Franklin Resources Inc. Buys New Shares in Soleno Therapeutics, Inc. $SLNO - MarketBeat

Click here to get full coverage on Noteworthy Wednesday Option Activity: SLNO, FWRD, CELH - Nasdaq

Noteworthy Wednesday Option Activity: SLNO, FWRD, CELH  Nasdaq

Noteworthy Wednesday Option Activity: SLNO, FWRD, CELH - Nasdaq

Click here to get full coverage on Soleno Stock: Blockbuster Launch In Progress (NASDAQ:SLNO) - Seeking Alpha

Soleno Stock: Blockbuster Launch In Progress (NASDAQ:SLNO)  Seeking Alpha

Soleno Stock: Blockbuster Launch In Progress (NASDAQ:SLNO) - Seeking Alpha

Click here to get full coverage on Soleno Therapeutics (NASDAQ:SLNO) Shares Gap Up - Still a Buy? - MarketBeat

Soleno Therapeutics (NASDAQ:SLNO) Shares Gap Up - Still a Buy?  MarketBeat

Soleno Therapeutics (NASDAQ:SLNO) Shares Gap Up - Still a Buy? - MarketBeat

Click here to get full coverage on Technical Reactions to SLNO Trends in Macro Strategies - news.stocktradersdaily.com

Technical Reactions to SLNO Trends in Macro Strategies  news.stocktradersdaily.com

Technical Reactions to SLNO Trends in Macro Strategies - news.stocktradersdaily.com

Click here to get full coverage on CRNX, CYTK, MDGL, SLNO: Top Analyst Outlines Her ‘Top Biotech Ideas for 2026’ - TipRanks

CRNX, CYTK, MDGL, SLNO: Top Analyst Outlines Her ‘Top Biotech Ideas for 2026’  TipRanks

CRNX, CYTK, MDGL, SLNO: Top Analyst Outlines Her ‘Top Biotech Ideas for 2026’ - TipRanks

Click here to get full coverage on Russell Investments Group Ltd. Acquires 82,932 Shares of Soleno Therapeutics, Inc. $SLNO - MarketBeat

Russell Investments Group Ltd. Acquires 82,932 Shares of Soleno Therapeutics, Inc. $SLNO  MarketBeat

Russell Investments Group Ltd. Acquires 82,932 Shares of Soleno Therapeutics, Inc. $SLNO - MarketBeat

Click here to get full coverage on SLNO Investor News: If You Have Suffered Losses in Soleno - GlobeNewswire

SLNO Investor News: If You Have Suffered Losses in Soleno  GlobeNewswire

SLNO Investor News: If You Have Suffered Losses in Soleno - GlobeNewswire

Click here to get full coverage on Johnson Fistel Begins Investigation on Behalf of Soleno Therapeu - GuruFocus

Johnson Fistel Begins Investigation on Behalf of Soleno Therapeu  GuruFocus

Johnson Fistel Begins Investigation on Behalf of Soleno Therapeu - GuruFocus

Click here to get full coverage on A Look at Soleno Therapeutics’s Valuation Following Legal Probes Into VYKAT XR Safety and Business Practices - Yahoo Finance

A Look at Soleno Therapeutics’s Valuation Following Legal Probes Into VYKAT XR Safety and Business Practices  Yahoo Finance

A Look at Soleno Therapeutics’s Valuation Following Legal Probes Into VYKAT XR Safety and Business Practices - Yahoo Finance

Click here to get full coverage on Soleno Therapeutics, Inc. Announces $100 Million Share Repurchase through Accelerated Share Repurchase Agreement | SLNO Stock News - Quiver Quantitative

Soleno Therapeutics, Inc. Announces $100 Million Share Repurchase through Accelerated Share Repurchase Agreement | SLNO Stock News  Quiver Quantitative

Soleno Therapeutics, Inc. Announces $100 Million Share Repurchase through Accelerated Share Repurchase Agreement | SLNO Stock News - Quiver Quantitative

Click here to get full coverage on INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc.- SLNO - PR Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc.- SLNO  PR Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc.- SLNO - PR Newswire

Click here to get full coverage on SLNO INVESTIGATION ALERT: Investigation Launched into Soleno Therapeutics, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm – Company Announcement - FT.com - Financial Times

SLNO INVESTIGATION ALERT: Investigation Launched into Soleno Therapeutics, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm – Company Announcement - FT.com  Financial Times

SLNO INVESTIGATION ALERT: Investigation Launched into Soleno Therapeutics, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm – Company Announcement - FT.com - Financial Times

Click here to get full coverage on Johnson Fistel Begins Investigation on Behalf of Soleno - GlobeNewswire

Johnson Fistel Begins Investigation on Behalf of Soleno  GlobeNewswire

Johnson Fistel Begins Investigation on Behalf of Soleno - GlobeNewswire

Click here to get full coverage on $SLNO stock is up 12% today. Here's what we see in our data. - Quiver Quantitative

$SLNO stock is up 12% today. Here's what we see in our data.  Quiver Quantitative

$SLNO stock is up 12% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Soleno Therapeutics, Inc. (SLNO) is a Great Momentum Stock: Should You Buy? - Yahoo Finance

Soleno Therapeutics, Inc. (SLNO) is a Great Momentum Stock: Should You Buy?  Yahoo Finance

Soleno Therapeutics, Inc. (SLNO) is a Great Momentum Stock: Should You Buy? - Yahoo Finance

Click here to get full coverage on Soleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report -- Hagens Berman - GlobeNewswire

Soleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report -- Hagens Berman  GlobeNewswire

Soleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report -- Hagens Berman - GlobeNewswire

Click here to get full coverage on Rosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – SLNO - Business Wire

Rosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – SLNO  Business Wire

SLNO

Price Chart

Key Statistics

Technicals

About SLNO

Latest News

Is Soleno Therapeutics (NASDAQ:SLNO) Using Debt Sensibly? - 富途牛牛

Soleno Therapeutics (SLNO) Valuation Check After Wolfe Research’s Optimistic New Coverage and Stock Pop - Yahoo Finance

Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses - PR Newswire

Advanced Charts

Top Gainers

Top Losers